Skip to main content

Project details

Strengthening national ethics review systems in East Africa

The SECRET project addresses a critical gap in Africa's clinical research ecosystem: the limited capacity of national research ethics review systems to provide quality ethical review and oversight to the ever-growing volume of clinical trials conducted across the region. Working in Uganda and Ethiopia, SECRET brings together a consortium of partners committed to building a robust, efficient, and internationally recognised research ethics infrastructure that will protect trial participants, attract quality research, and strengthen health research systems across East Africa.

The challenge

Clinical trial activity in sub-Saharan Africa has increased substantially in recent years, yet the regulatory and ethical oversight infrastructure has not kept pace. The key gaps in clinical trial review and oversight in the region include:

  • Limited clinical trials ethics review capacity: Few research ethics committees (RECs) have the capacity to review and provide oversight for clinical trials in the region.
  • Absent accreditation systems: National accreditation frameworks that guarantee the quality of ethical review are largely absent, raising questions about the protection of research participants.
  • Low trial registration: Many clinical trials, particularly single-country studies, remain unregistered, undermining transparency and accountability in research.
  • Paper-based protocol submission systems: Nearly half of RECs across the region still rely on paper-based protocol submission systems, limiting efficiency and data management capacity.
  • Emergency response gaps: Slow ethical review turnaround during outbreaks and epidemics constrains Africa's ability to generate timely research evidence when it is most needed.

The project

SECRET takes a systems-strengthening approach across four interlinked objectives:

  1. National accreditation systems. Establishing formal accreditation frameworks for research ethics committees (RECs) in Ethiopia, ensuring that ethical review meets national and international quality standards and is recognised by funders, regulators, and the global research community.2
  2. Capacity building for REC review of clinical trials. Providing targeted training and support to RECs to strengthen their ability to review complex clinical trials, including those conducted during outbreaks and epidemics
  3. National clinical trial registries. Establishing a national clinical trial registry in Uganda, linked to the Pan-African Clinical Trials Registry and aligned with the WHO international registration standards, to increase transparency and accountability in research conducted in the region.
  4. Digital protocol submission systems. Developing and implementing electronic protocol submission systems to modernise REC operations, reduce administrative burden, improve turnaround times, and enable better data management and reporting.

Impact

By the end of the project, SECRET will have created a stronger, more efficient, and internationally recognised research ethics environment in Uganda and Ethiopia. Specifically, the project will:

  • Increase participation of Uganda and Ethiopia in high-quality clinical trials by ensuring their ethics review systems meet international standards.
  • Improve the protection of research participants through rigorous, well-resourced, and independently accredited ethics review.
  • Provide a replicable model for national ethics system strengthening that can be adapted and scaled across East Africa and beyond.
  • Strengthen Africa's capacity to conduct timely, well-regulated research during health emergencies and outbreaks.
  • Contribute to Sustainable Development Goal 3 on good health and well-being by enabling more and better clinical research on poverty-related and neglected infectious diseases in the region.

Consortium map

Coordinator

Scientific project leader

UGANDA NATIONAL HEALTH RESEARCH ORGANISATION

Location: Entebbe, Uganda

Beneficiaries

NUVOTEQ (PTY) LTD

Location
GAUTENG, South Africa
Global Health EDCTP3 funding
€240 376,25
Total cost
€240 376,25

SAINT PAUL MILLENNIUM MEDICAL COLLEGE

Location
Addis Ababa, Ethiopia
Global Health EDCTP3 funding
€104 637,50
Total cost
€104 637,50

MINISTRY OF EDUCATION OF FEDERAL REPUBLIC OF ETHIOPIA,

Location
Addis Ababa, Ethiopia
Global Health EDCTP3 funding
€116 000,00
Total cost
€116 000,00

MAKERERE UNIVERSITY

Location
Kampala, Uganda
Global Health EDCTP3 funding
€100 000,00
Total cost
€100 000,00

THE NATIONAL DRUG AUTHORITY

Location
Central Division, Uganda
Global Health EDCTP3 funding
€100 600,00
Total cost
€100 600,00

UGANDA NATIONAL HEALTH RESEARCH ORGANISATION

Location
Entebbe, Uganda
Global Health EDCTP3 funding
€100 455,00
Total cost
€100 455,00
Global Health EDCTP3-funded PANGenS project logo
  • In progress
  • Tuberculosis
  • Malaria
  • Cross-disease or disease unspecific
Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...
Global Health EDCTP3-funded UTI-Diag project logo
  • In progress
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...
Global Health EDCTP3-funded ASPIRE project logo
  • In progress
  • Lower respiratory tract infections
  • Other childhood infectious diseases
  • Cross-disease or disease unspecific
Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...